These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 38865961)

  • 1. Mast cells: The Janus of type 2 inflammation.
    Kotrba J; Dudeck A
    Immunity; 2024 Jun; 57(6):1182-1184. PubMed ID: 38865961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mast cells control lung type 2 inflammation via prostaglandin E
    Alhallak K; Nagai J; Zaleski K; Marshall S; Salloum T; Derakhshan T; Hayashi H; Feng C; Kratchmarov R; Lai J; Kuchibhotla V; Nishida A; Balestrieri B; Laidlaw T; Dwyer DF; Boyce JA
    Immunity; 2024 Jun; 57(6):1274-1288.e6. PubMed ID: 38821053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated mast cells synthesize and release soluble ST2-a decoy receptor for IL-33.
    Bandara G; Beaven MA; Olivera A; Gilfillan AM; Metcalfe DD
    Eur J Immunol; 2015 Nov; 45(11):3034-44. PubMed ID: 26256265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mast cell-dependent IL-33/ST2 signaling is protective against the development of airway hyperresponsiveness in a house dust mite mouse model of asthma.
    Zoltowska Nilsson AM; Lei Y; Adner M; Nilsson GP
    Am J Physiol Lung Cell Mol Physiol; 2018 Mar; 314(3):L484-L492. PubMed ID: 29146574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the Prostaglandin E2 receptor EP2 prevents house dust mite-induced airway hyperresponsiveness and inflammation by restraining mast cells' activity.
    Serra-Pages M; Torres R; Plaza J; Herrerias A; Costa-Farré C; Marco A; Jiménez M; Maurer M; Picado C; de Mora F
    Clin Exp Allergy; 2015 Oct; 45(10):1590-600. PubMed ID: 25823713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukotriene D4 and prostaglandin E2 signals synergize and potentiate vascular inflammation in a mast cell-dependent manner through cysteinyl leukotriene receptor 1 and E-prostanoid receptor 3.
    Kondeti V; Al-Azzam N; Duah E; Thodeti CK; Boyce JA; Paruchuri S
    J Allergy Clin Immunol; 2016 Jan; 137(1):289-298. PubMed ID: 26255103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mast cells are essential intermediaries in regulating IL-33/ST2 signaling for an immune network favorable to mucosal healing in experimentally inflamed colons.
    He Z; Song J; Hua J; Yang M; Ma Y; Yu T; Feng J; Liu B; Wang X; Li Y; Li J
    Cell Death Dis; 2018 Dec; 9(12):1173. PubMed ID: 30518915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutting edge: The ST2 ligand IL-33 potently activates and drives maturation of human mast cells.
    Allakhverdi Z; Smith DE; Comeau MR; Delespesse G
    J Immunol; 2007 Aug; 179(4):2051-4. PubMed ID: 17675461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin E2-induced inflammation: Relevance of prostaglandin E receptors.
    Kawahara K; Hohjoh H; Inazumi T; Tsuchiya S; Sugimoto Y
    Biochim Biophys Acta; 2015 Apr; 1851(4):414-21. PubMed ID: 25038274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-33/ST2 axis promotes mast cell survival via BCLXL.
    Wang JX; Kaieda S; Ameri S; Fishgal N; Dwyer D; Dellinger A; Kepley CL; Gurish MF; Nigrovic PA
    Proc Natl Acad Sci U S A; 2014 Jul; 111(28):10281-6. PubMed ID: 24982172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin E2 promotes degranulation-independent release of MCP-1 from mast cells.
    Nakayama T; Mutsuga N; Yao L; Tosato G
    J Leukoc Biol; 2006 Jan; 79(1):95-104. PubMed ID: 16275896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PGE2-EP2-mast cell axis: an antiasthma mechanism.
    Torres R; Picado C; de Mora F
    Mol Immunol; 2015 Jan; 63(1):61-8. PubMed ID: 24768319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human mast cells express multiple EP receptors for prostaglandin E2 that differentially modulate activation responses.
    Feng C; Beller EM; Bagga S; Boyce JA
    Blood; 2006 Apr; 107(8):3243-50. PubMed ID: 16357326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beyond IgE: Alternative Mast Cell Activation Across Different Disease States.
    Lyons DO; Pullen NA
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mast Cells as Key Players in Allergy and Inflammation.
    González-de-Olano D; Álvarez-Twose I
    J Investig Allergol Clin Immunol; 2018 Dec; 28(6):365-378. PubMed ID: 30530385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlative Study on Impaired Prostaglandin E2 Regulation in Epicardial Adipose Tissue and its Role in Maladaptive Cardiac Remodeling via EPAC2 and ST2 Signaling in Overweight Cardiovascular Disease Subjects.
    Vianello E; Dozio E; Bandera F; Froldi M; Micaglio E; Lamont J; Tacchini L; Schmitz G; Corsi Romanelli MM
    Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31947646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin E
    Zhou Y; Wang W; Zhao C; Wang Y; Wu H; Sun X; Guan Y; Zhang Y
    Front Immunol; 2018; 9():501. PubMed ID: 29593738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PGE
    Rastogi S; Willmes DM; Nassiri M; Babina M; Worm M
    J Allergy Clin Immunol; 2020 Dec; 146(6):1387-1396.e13. PubMed ID: 32407837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clock-dependent temporal regulation of IL-33/ST2-mediated mast cell response.
    Kawauchi T; Ishimaru K; Nakamura Y; Nakano N; Hara M; Ogawa H; Okumura K; Shibata S; Nakao A
    Allergol Int; 2017 Jul; 66(3):472-478. PubMed ID: 28259547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL-33/ST2 signalling and crosstalk with FcεRI and TLR4 is targeted by the parasitic worm product, ES-62.
    Ball DH; Al-Riyami L; Harnett W; Harnett MM
    Sci Rep; 2018 Mar; 8(1):4497. PubMed ID: 29540770
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.